inVentiv Health Launches Phase I Services to the U.S.
New Phase I clinical in Miami offers gateway location to Latin America.
inVentiv Health marked the official opening of its new Phase I clinic in the United States, located at the University of Miami Life Science and Technology Park. Key features of the clinic include, but are not limited to:
- 44-bed clinic to expedite progression to Proof of Concept (PoC)
- existing Phase I - Phase IV bioanalytical labs capabilities
- use of new Mytrus Enroll® eConsent technology
- gateway location to Latin America
Read the full release.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
